Similar content being viewed by others
This article is cited by
-
BCR-ABL triggers a glucose-dependent survival program during leukemogenesis through the suppression of TXNIP
Cell Death & Disease (2023)
-
Characterization of K562 cells: uncovering novel chromosomes, assessing transferrin receptor expression, and probing pharmacological therapies
Cellular and Molecular Life Sciences (2023)
-
A predictive scoring system for therapy-failure in persons with chronic myeloid leukemia receiving initial imatinib therapy
Leukemia (2022)
-
Exome, transcriptome and miRNA analysis don’t reveal any molecular markers of TKI efficacy in primary CML patients
BMC Medical Genomics (2019)
-
Targeted blocking of miR328 lysosomal degradation with alkalized exosomes sensitizes the chronic leukemia cells to imatinib
Applied Microbiology and Biotechnology (2019)